Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

JAK inhibitors offer new hope for treating severe alopecia areata.

New medications could improve treatment for severe alopecia areata in Australia.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Cannabinoids may help treat various skin conditions.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Liposomal curcumin improves skin cancer treatment effectiveness while sparing normal cells.

Proper nutrition can help balance the immune system and reduce allergies.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Geranium sibiricum may help manage diabetic complications by inhibiting a key enzyme.

Both genetics and lifestyle factors contribute to male pattern baldness.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.

Melatonin helps broccoli roots produce anti-cancer compounds by controlling nitric oxide and hydrogen peroxide levels.

Combining herbal medicines with modern delivery systems may improve alopecia treatment.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Personalized vitamin and trace element treatment improves hair density and reduces hair loss in men with early-stage androgenic alopecia.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.